Work

31 Temozolomide (TMZ) targets only glioblastoma with a silenced MGMT-gene. Results of a translational companion study to EORTC 26981/NCIC CE.3 of radiotherapy ± TMZ

Year: 2004

Type: conference-abstract

Source: European Journal of Cancer Supplements

DOI: 10.1016/s1359-6349(04)80039-9

Authors: M. Hegi, A. Diserens, M. Hamou, T. Gorlia, M. Weller, J. Kros, J. Hainfellner, U. Bogdahn, G. Cairncross, R. Stupp

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics (clinical)

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2015614848

Cites:

Cited by: 4

Related to: 10